Jean‐François Peyron

5.9k total citations · 1 hit paper
86 papers, 4.7k citations indexed

About

Jean‐François Peyron is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Jean‐François Peyron has authored 86 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 31 papers in Immunology and 29 papers in Cancer Research. Recurrent topics in Jean‐François Peyron's work include NF-κB Signaling Pathways (23 papers), Immune Response and Inflammation (12 papers) and Glycosylation and Glycoproteins Research (10 papers). Jean‐François Peyron is often cited by papers focused on NF-κB Signaling Pathways (23 papers), Immune Response and Inflammation (12 papers) and Glycosylation and Glycoproteins Research (10 papers). Jean‐François Peyron collaborates with scholars based in France, United States and Monaco. Jean‐François Peyron's co-authors include Véronique Imbert, Antonia Livolsi, Patrick Auberger, Bernard Rossi, Dorota Czerucka, Virginie Bottero, Patrick Rampal, D Farahifar, V. Busuttil and Emmanuel Griessinger and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Jean‐François Peyron

86 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tyrosine Phosphorylation of IκB-α Activates NF-κB without Proteolytic Degradation of IκB-α

1996 597 citations Véronique Imbert, Antonia Livolsi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jean‐François Peyron France	39	2.5k	1.4k	1.2k	723	427	86	4.7k
Véronique Imbert France	31	1.8k 0.7×	987 0.7×	956 0.8×	561 0.8×	353 0.8×	48	3.4k
Javier Naval Spain	40	3.4k 1.4×	1.6k 1.1×	717 0.6×	837 1.2×	348 0.8×	106	5.1k
Ezra Burstein United States	39	2.5k 1.0×	961 0.7×	709 0.6×	820 1.1×	317 0.7×	88	4.9k
Franco Di Padova Switzerland	34	2.8k 1.1×	2.3k 1.7×	908 0.7×	720 1.0×	149 0.3×	70	6.1k
P A Campbell United States	29	3.1k 1.2×	2.4k 1.7×	475 0.4×	467 0.6×	209 0.5×	54	6.0k
Roberta Visconti Italy	34	2.1k 0.8×	876 0.6×	649 0.5×	1.2k 1.6×	106 0.2×	73	4.7k
Edgar Schreiber Switzerland	18	3.1k 1.2×	1.5k 1.1×	1.0k 0.8×	926 1.3×	125 0.3×	27	5.4k
Paul Brennan United Kingdom	43	2.8k 1.1×	1.6k 1.1×	608 0.5×	1.0k 1.4×	217 0.5×	95	5.5k
Lutz Graeve Germany	37	2.4k 0.9×	2.4k 1.7×	867 0.7×	3.1k 4.3×	248 0.6×	85	6.5k
Ryan D. Michalek United States	23	2.1k 0.8×	3.0k 2.1×	1.1k 0.9×	882 1.2×	175 0.4×	35	5.7k

Countries citing papers authored by Jean‐François Peyron

Since Specialization

Citations

This map shows the geographic impact of Jean‐François Peyron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐François Peyron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐François Peyron more than expected).

Fields of papers citing papers by Jean‐François Peyron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐François Peyron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐François Peyron. The network helps show where Jean‐François Peyron may publish in the future.

Co-authorship network of co-authors of Jean‐François Peyron

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐François Peyron. A scholar is included among the top collaborators of Jean‐François Peyron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐François Peyron. Jean‐François Peyron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Calvo, Julien, Irina Naguibneva, Benjamin Uzan, et al.. (2024). High CD44 expression and enhanced E-selectin binding identified as biomarkers of chemoresistant leukemic cells in human T-ALL. Leukemia. 39(2). 323–336. 2 indexed citations

Imbert, Véronique, Julien Calvo, Françoise Pflumio, et al.. (2024). Identifying Candidate Gene Drivers Associated with Relapse in Pediatric T-Cell Acute Lymphoblastic Leukemia Using a Gene Co-Expression Network Approach. Cancers. 16(9). 1667–1667. 2 indexed citations

Rochet, Nathalie, Marielle Nebout, Agnès Guerci, et al.. (2023). Repurposing the Bis-Biguanide Alexidine in Combination with Tyrosine Kinase Inhibitors to Eliminate Leukemic Stem/Progenitor Cells in Chronic Myeloid Leukemia. Cancers. 15(3). 995–995. 3 indexed citations

Griessinger, Emmanuel, Diego A. Pereira‐Martins, Marielle Nebout, et al.. (2023). Oxidative Phosphorylation Fueled by Fatty Acid Oxidation Sensitizes Leukemic Stem Cells to Cold. Cancer Research. 83(15). 2461–2470. 7 indexed citations

Peyron, Jean‐François, et al.. (2022). Identification of potentially anti-COVID-19 active drugs using the connectivity MAP. PLoS ONE. 17(1). e0262751–e0262751. 4 indexed citations

Gilles, Arnaud, Giulia Biondani, Ottilie von Loeffelholz, et al.. (2020). Targeting the Human 80S Ribosome in Cancer: From Structure to Function and Drug Design for Innovative Adjuvant Therapeutic Strategies. Cells. 9(3). 629–629. 47 indexed citations

Contenti, Julie, Maeva Dufies, Julien Parola, et al.. (2020). Co‐culture of human fibroblasts, smooth muscle and endothelial cells promotes osteopontin induction in hypoxia. Journal of Cellular and Molecular Medicine. 24(5). 2931–2941. 7 indexed citations

Griessinger, Emmanuel, Fernando Anjos‐Afonso, Jacques Vargaftig, et al.. (2016). Frequency and Dynamics of Leukemia-Initiating Cells during Short-term Ex Vivo Culture Informs Outcomes in Acute Myeloid Leukemia Patients. Cancer Research. 76(8). 2082–2086. 19 indexed citations

Myasnikov, Alexander G., S. Kundhavai Natchiar, Marielle Nebout, et al.. (2016). Structure–function insights reveal the human ribosome as a cancer target for antibiotics. Nature Communications. 7(1). 12856–12856. 65 indexed citations

10.

Ben‐Sahra, Issam, et al.. (2014). Metformin: A metabolic disruptor and anti-diabetic drug to target human leukemia. Cancer Letters. 346(2). 188–196. 53 indexed citations

11.

Mary, D. A. S. G., Emmanuel Griessinger, Johanna Chiche, et al.. (2013). Pharmacological inhibition of carbonic anhydrase XII interferes with cell proliferation and induces cell apoptosis in T-cell lymphomas. Cancer Letters. 333(1). 76–88. 41 indexed citations

12.

Piche, T., Marie‐Christine Saint‐Paul, Raffaella Dainese, et al.. (2008). Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome. Gut. 57(4). 468–473. 155 indexed citations

13.

Cochet, Olivia, Catherine Frelin, Jean‐François Peyron, & Véronique Imbert. (2005). Constitutive activation of STAT proteins in the HDLM-2 and L540 Hodgkin lymphoma-derived cell lines supports cell survival. Cellular Signalling. 18(4). 449–455. 41 indexed citations

14.

Magné, Nicolas, et al.. (2004). Biomodulation du facteur de transcription NF-κB par les radiations ionisantes. Cancer/Radiothérapie. 8(5). 315–321. 3 indexed citations

15.

Bui, Nguyen Truc, Antonia Livolsi, Jean‐François Peyron, & Jochen H.M. Prehn. (2001). Activation of Nuclear Factor κb and bcl-x Survival Gene Expression by Nerve Growth Factor Requires Tyrosine Phosphorylation of IκBα. The Journal of Cell Biology. 152(4). 753–764. 123 indexed citations

16.

Rupec, R., Dominique Poujol, Josiane Grosgeorge, et al.. (1999). Structural analysis, expression, and chromosomal localization of the mouse ikba gene. Immunogenetics. 49(5). 395–403. 17 indexed citations

17.

Péleraux, Annick, et al.. (1998). Inhibition of HIV-1 Replication by a Monoclonal Antibody Directed toward the Complementarity Determining Region 3-Like Domain of CD4 in CD45 Expressing and CD45-Deficient Cells. Virology. 242(1). 233–237. 9 indexed citations

18.

Guérin, Sandrine, Bernard Mari, Nathalie Belhacène, et al.. (1997). CD10 (Endopeptidase 24.11) Is a Thymic Peptide-Degrading Enzyme Possibly Involved in the Regulation of Thymocyte Functions. Cellular Immunology. 175(1). 85–91. 9 indexed citations

19.

Giordanengo, Valérie, et al.. (1995). Lymphocytic CD43 and CD45 bear sulfate residues potentially implicated in cell to cell interactions. European Journal of Immunology. 25(1). 274–278. 14 indexed citations

20.

Manié, Serge N., Joanna Kubar, Bernard Ferruà, et al.. (1993). CD3-stimulated Jurkat T cells mediate IL-1 beta production in monocytic THP-1 cells. Role of LFA-1 molecule and participation of CD69 T cell antigen.. PubMed. 4(1). 7–13. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact